cas 2359672-84-5|| where to buy 3-(4-fluorophenyl)-3-hydroxy-1-(2-methoxyphenyl)-2H,3H,5H,6H,7H,8H,9H-1lambda5-imidazo[1,2-a]azepin-1-ylium bromide

Nom du produit:3-(4-fluorophenyl)-3-hydroxy-1-(2-methoxyphenyl)-2H,3H,5H,6H,7H,8H,9H-1lambda5-imidazo[1,2-a]azepin-1-ylium bromide

IUPAC Name:3-(4-fluorophenyl)-3-hydroxy-1-(2-methoxyphenyl)-2H,3H,5H,6H,7H,8H,9H-1λ⁵-imidazo[1,2-a]azepin-1-ylium bromide

: CAS：2359672-84-5; Formule moléculaire：C21H24BrFN2O2; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2359672-84-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2359672-84-5; Formule moléculaire:C21H24BrFN2O2; Point de fusion:-; Code SMILES:[Br-].COC1=C(C=CC=C1)[N+]1=C2CCCCCN2C(O)(C1)C1=CC=C(F)C=C1; Densité:

: Numéro de catalogue:CM845962; Poids moléculaire:435.34; Point d'ébullition:; N° Mdl:; Stockage:

: Imidazolines; Imidazolines are a class of heterocycles derived from imidazoles by reduction of one of the two double bonds. Three isomers are known, 2-imidazoline, 3-imidazoline and 4-imidazoline. 2 and 3-imidazolines contain imine centers, while 4-imidazolines contain alkene groups. The 2-imidazoline group occurs in several drugs. Imidazolines are an important class of compounds found in many natural and medicinal products. These compounds are also used as intermediates in the synthesis of organic molecules. Furthermore, chiral imidazolines are widely used as organic catalysts for the synthesis of various natural and synthetic organic compounds.

: Azepanes; The use of azepane as a scaffold for drug discovery remains of interest. The azepane linker is the key to efficient activity. A number of seven-membered ring derivatives have been prepared or investigated for their potential or actual pharmacological properties. Examples include azaalkane derivatives as PKB (protein kinase B) inhibitors.